EPA approves honeybee miticide for all 50 states
"Canada’s regulatory agency granted full approval to Apivar in July 2012, so, now that the U.S. is on board, we are very enthusiastic about the impact that Apivar can have on the health of the North American honeybee population," Nobre said. "Early indications tell us the product is being warmly welcomed in the U.S. market, and we look forward to moving Apivar into the Mexican market in the very near future."
Véto-pharma S.A. is a veterinary pharmaceutical company that develops and markets innovative products to help commercial and hobbyist beekeepers prevent and control hive diseases and improve honeybee health. Véto-pharma's products are sold to beekeepers through distributors in North America, Europe and Asia. Headquartered in Paris, the Company's U.S. operations are based in New York, NY. Visit www.apivar.net for more information.
- Sign-up begins for USDA disaster assistance programs
- Grain futures lagged the other ag markets Wednesday
- Pacific Coast Terminals and K+S Potash Canada sign agreement
- Soy, cotton futures led the ag markets Wednesday morning
- Monthly fertilizer prices: Comparing 2014 through 2009
- USDA releases April water supply forecast for the West
- Commentary: Blame anti-GMO groups for deaths
- Julie Borlaug says biotech is necessary in fight against hunger
- What does “sustainable” food and agriculture really mean?
- Climate change will reduce crop yields sooner than we thought
- Ohio bill to require certification to apply fertilizer
- Carbon-dioxide hurts nitrogen assimilation by plants